Related Experiment Video
Updated: May 6, 2026

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein
Published on: June 30, 2019
Structure of LIMP-2 provides functional insights with implications for SR-BI and CD36
Dante Neculai1, Michael Schwake, Mani Ravichandran
1Cell Biology Program, The Hospital for Sick Children, Toronto M5G 1X8, Canada.
Insights
The CD36 superfamily regulates lipid metabolism and immunity. Researchers determined the LIMP-2 structure, revealing a tunnel crucial for selective lipid transfer in SR-BI and CD36.
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- The CD36 superfamily of scavenger receptors are key regulators of lipid metabolism and innate immunity.
- These receptors recognize lipoproteins and pathogen-associated molecular patterns, playing roles in diseases like atherosclerosis and Alzheimer's.
- Structural information for CD36 family members has been limited, hindering functional understanding.
Purpose of the Study:
- To determine the crystal structure of LIMP-2 (CD36 superfamily member).
- To infer the structures of SR-BI and CD36 via homology modeling.
- To elucidate the mechanism of selective lipid transfer mediated by these receptors.
Main Methods:
- X-ray crystallography to determine LIMP-2 structure.
- Homology modeling to predict SR-BI and CD36 structures.
- Site-directed mutagenesis of SR-BI to investigate functional roles of structural features.
Main Results:
- The crystal structure of LIMP-2 revealed a helical bundle with a large, xuyên suốt cavity.
- Homology modeling suggested similar structural features for SR-BI and CD36.
- Mutagenesis of SR-BI confirmed the cavity acts as a tunnel for cholesterol ester transfer to the plasma membrane.
Conclusions:
- The identified tunnel in LIMP-2, SR-BI, and CD36 provides a structural basis for their role in selective lipid transfer.
- This structural insight advances understanding of lipid metabolism and scavenger receptor function in health and disease.
Abstract:
Members of the CD36 superfamily of scavenger receptor proteins are important regulators of lipid metabolism and innate immunity. They recognize normal and modified lipoproteins, as well as pathogen-associated molecular patterns. The family consists of three members: SR-BI (which delivers cholesterol to the liver and steroidogenic organs and is a co-receptor for hepatitis C virus), LIMP-2/LGP85 (which mediates lysosomal delivery of β-glucocerebrosidase and serves as a receptor for enterovirus 71 and coxsackieviruses) and CD36 (a fatty-acid transporter and receptor for phagocytosis of effete cells and Plasmodium-infected erythrocytes). Notably, CD36 is also a receptor for modified lipoproteins and β-amyloid, and has been implicated in the pathogenesis of atherosclerosis and of Alzheimer's disease. Despite their prominent roles in health and disease, understanding the function and abnormalities of the CD36 family members has been hampered by the paucity of information about their structure. Here we determine the crystal structure of LIMP-2 and infer, by homology modelling, the structure of SR-BI and CD36. LIMP-2 shows a helical bundle where β-glucocerebrosidase binds, and where ligands are most likely to bind to SR-BI and CD36. Remarkably, the crystal structure also shows the existence of a large cavity that traverses the entire length of the molecule. Mutagenesis of SR-BI indicates that the cavity serves as a tunnel through which cholesterol(esters) are delivered from the bound lipoprotein to the outer leaflet of the plasma membrane. We provide evidence supporting a model whereby lipidic constituents of the ligands attached to the receptor surface are handed off to the membrane through the tunnel, accounting for the selective lipid transfer characteristic of SR-BI and CD36.
More Related Videos
Related Concept Videos
Functional Brain Systems: Limbic System
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...

